Coccidioidomycosis cost-effectiveness of therapy

Coccidioidomycosis Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes Coccidioides immitis Coccidioides posadasii
Differentiating Coccidioidomycosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Coccidioidomycosis cost-effectiveness of therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Coccidioidomycosis cost-effectiveness of therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Coccidioidomycosis cost-effectiveness of therapy
CDC on Coccidioidomycosis cost-effectiveness of therapy
Coccidioidomycosis cost-effectiveness of therapy in the news
Blogs on Coccidioidomycosis cost-effectiveness of therapy
Directions to Hospitals Treating Coccidioidomycosis
Risk calculators and risk factors for Coccidioidomycosis cost-effectiveness of therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]:Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]

Overview

Given the morbidity and mortality associated with coccidioidomycosis infection, and the low cost of safe and effective antifungals, current pharmacotherapy to treat coccidioidomycosis is relatively cost-effective.